MedTrace Logo

Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome

NCT03547453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-02-13

No results posted yet for this study

Summary

The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict PCOS.

Conditions

  • Polycystic Ovary Syndrome (PCOS)
  • Menstrual Irregularity
  • Overweight and Obesity

Sponsors & Collaborators

Principal Investigators

  • Marla E. Lujan, PhD · Cornell University

  • Kathleen Hoeger, MD · University of Rochester

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-04
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547453 on ClinicalTrials.gov